Publications by authors named "Michael Devit"

Claim this Profile
D
Dolaflexin: A Novel Antibody-Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect.
Aleksandr V Yurkovetskiy, Natalya D Bodyak, Mao Yin, Joshua D Thomas, Susan M Clardy, Michael J DeVit

Mol Cancer Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Dolaflexin-based Antibody-Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b.
Natalya D Bodyak, Rebecca Mosher, Aleksandr V Yurkovetskiy, Mao Yin, Charlie Bu, Michael J DeVit

Mol Cancer Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
Christine E Bulawa, Stephen Connelly, Michael Devit, Lan Wang, Charlotte Weigel

Proc Natl Acad Sci U S A· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic exploration of essential yeast gene function with temperature-sensitive mutants.
Zhijian Li, Franco J Vizeacoumar, Sondra Bahr, Jingjing Li, Jonas Warringer, Michael Devit

Nat Biotechnol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forcing interactions as a genetic screen to identify proteins that exert a defined activity.
Michael Devit, Paul J Cullen, Margaret Branson, George F Sprague, Stanley Fields

Genome Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein.
Stephen Willingham, Tiago Fleming Outeiro, Michael J DeVit, Susan L Lindquist, Paul J Muchowski

Science· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis